LE WE PMID CA
P532083P53

AMP activated protein kinase

Antiinflammatory compounds

ARF

ASPP protein family

ASPP1

ASPP2

ATM

Autophagy

Axin

Bicoid

BRCA1

BRCA2

BRIP1

Caveolin and caveoles

Cdh1

Cell differentiation

Cell Secretion (Exosomes)

Cell senescence

Centrosome

CHE1

CHEK2

Chk2

Chmp4C

Chromatin immunoprecipitation

CycG2

Daxx

DEC2

DNA (Repair and Toxicology)

DRAM

E2F

Endoplasmic reticulum (associated degradation)

Endosom

ERS UFR (Induced Mediators)

Fbxw7

FoxO

Genome toxicity

GSK3

Hedgehog

HIF1alpha und HIF1 (BASKET)

HTLV1

Hupki mouse

iASPP

IGF1

IGFBP3

Interleukin24 MDA7

Jab1

LET7

Leukemia (chronic lymphatic)

Li Fraumeni syndrome

LKB1

Mammary gland (Neoplasia)

MDM2

MDM4

MDMX

miRNA 145

MiRNA 146a

miRNA 15 16a

miRNA 26

miRNA 29

miRNA 30

miRNA 34

Mitochondria (BASKET)

MTOR

Myc

Natural products

NBS1

Neoplasia (Invasion and metastasis)

Neoplasia (Tumor biology and immunology)

NFKB

Numb

P53

P63

P73

PALB2

Pentose shunt

Pervanadate ttTyrosine Phosphatases

PGC1alpha

Pifithrin alpha ttp53

Pin1

Podosome

Prohibitins

Protein (ptm Methylation)

Protein kinase B Akt

PTEN MMAC1 TEP1

PTTG1

Rad50

Rb retinoblastoma gene

Research ethics

RNA (Binding proteins)

RNA (MicroRNA)

Sestrin1

Sestrin2

SIRT1

SKP2

Skp2B

STAT1

Stem cell (Adult somatic derived reprogrammed)

Stem cell (Embryonal)

Stem cell (Induced pluripotential)

Synoviolin

Tissue (Cell Biology)

TLS FUS

TRA1

TRIM32

TSAP6

TSC1 Hamartin

TSC2 Tuberin

Ubiquitin

Warburg effect

WT1

YB1

2006  
1
The p53 family in nervous system development and disease.
[16805769] J Neurochem 97(6): 1571-84 (2006)
2009  
2
2003  
3
TP53 and mutations in human cancer.
[12673364] Acta Biochim Pol 50(1): 231-8 (2003)
2007  
4
The p53-MDM2 network: from oscillations to apoptosis.
[17914240] J Biosci 32(5): 991-7 (2007)
2010  
5
Transcriptional control of the proliferation cluster by the tumor suppressor p53.
[20024063] Mol Biosyst 6(1): 17-29 (2010)
2008  
6
2009  
7
The p53 Pathway Encounters the MicroRNA World.
[19881912] Curr Genomics 10(3): 194-7 (2009)
2010  
8
The role of p53 in apoptosis.
[20193641] Discov Med 9(45): 145-52 (2010)
2007  
9
p53 and its isoforms in cancer.
[17637683] Br J Cancer 97(3): 277-82 (2007)
2004  
10
Targeting the p53-MDM2 interaction to treat cancer.
[15452548] Br J Cancer 91(8): 1415-9 (2004)
1997  
11
Li-Fraumeni syndrome--a molecular and clinical review.
[9218725] Br J Cancer 76(1): 1-14 (1997)
1994  
12
The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.
[8123467] Br J Cancer 69(3): 409-16 (1994)
2008  
13
Structural and functional basis for therapeutic modulation of p53 signaling.
[18927276] Clin Cancer Res 14(20): 6376-86 (2008)
2008  
14
Targeting the MDM2-p53 interaction for cancer therapy.
[18765522] Clin Cancer Res 14(17): 5318-24 (2008)
2000  
15
Gain-of-function mutations in the tumor suppressor gene p53.
[10873062] Clin Cancer Res 6(6): 2138-45 (2000)
1996  
16
Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies.
[8841019] J Natl Cancer Inst 88(20): 1442-55 (1996)
2007  
17
The guardian's little helper: microRNAs in the p53 tumor suppressor network.
[18056431] Cancer Res 67(23): 11099-101 (2007)
1994  
18
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
[8069852] Cancer Res 54(18): 4855-78 (1994)
2008  
19
The p53 family and programmed cell death.
[18955976] Oncogene 27(50): 6507-21 (2008)
2002  
20
Deconstruction of p53 functions and regulation.
[12447685] Oncogene 21(54): 8223-31 (2002)
2002  
21
Loss of p53 and centrosome hyperamplification.
[12214254] Oncogene 21(40): 6234-40 (2002)
2001  
22
p53 binds the nuclear matrix in normal cells: binding involves the proline-rich domain of p53 and increases following genotoxic stress.
[11571642] Oncogene 20(39): 5449-58 (2001)
2001  
23
The role of tetramerization in p53 function.
[11420672] Oncogene 20(21): 2611-7 (2001)
2001  
24
Regulation of the G2/M transition by p53.
[11313928] Oncogene 20(15): 1803-15 (2001)
1999  
25
1999  
26
Twenty years of p53 research: structural and functional aspects of the p53 protein.
[10618702] Oncogene 18(53): 7621-36 (1999)
1999  
27
Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53.
[10618711] Oncogene 18(53): 7706-17 (1999)
1999  
28
The role of the E6-p53 interaction in the molecular pathogenesis of HPV.
[10618709] Oncogene 18(53): 7690-700 (1999)
1999  
29
Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase.
[10618707] Oncogene 18(53): 7676-80 (1999)
1999  
30
Mechanisms of switching on p53: a role for covalent modification?
[10618706] Oncogene 18(53): 7666-75 (1999)
1999  
31
p53 regulation by post-translational modification and nuclear retention in response to diverse stresses.
[10618705] Oncogene 18(53): 7656-65 (1999)
1999  
32
Regulation of p53 in response to DNA damage.
[10618704] Oncogene 18(53): 7644-55 (1999)
1999  
33
Regulation of p53 stability.
[10618703] Oncogene 18(53): 7637-43 (1999)
1999  
34
The cellular response to p53: the decision between life and death.
[10557106] Oncogene 18(45): 6145-57 (1999)
1998  
35
Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress.
[9916991] Oncogene 17(25): 3287-99 (1998)
2005  
36
Structural basis for gene activation by p53 family members.
[16294021] Cancer Biol Ther 4(11): 1178-85 (2005)
2007  
37
p53-based cancer therapies: Is defective p53 the Achilles heel of the tumor?
[17088261] Carcinogenesis 28(1): 13-20 (2007)
2006  
38
Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications.
[16308315] Carcinogenesis 27(4): 673-81 (2006)
2005  
39
The p53 story: layers of complexity.
[15817608] Carcinogenesis 26(7): 1161-9 (2005)
2001  
40
p53 protein at the hub of cellular DNA damage response pathways through sequence-specific and non-sequence-specific DNA binding.
[11375889] Carcinogenesis 22(6): 851-60 (2001)
2010  
41
Targeting p53 for Novel Anticancer Therapy.
[20165689] Transl Oncol 3(1): 1-12 (2010)
2010  
42
Behind the scenes: unravelling the molecular mechanisms of p53 target gene selectivity (Review).
[20878053] Int J Oncol 37(5): 1061-70 (2010)
1998  
43
1992  
44
p53: the ultimate tumor suppressor gene?
[1397838] FASEB J 6(13): 3169-76 (1992)
2003  
45
2000  
46
The p53/p63/p73 family of transcription factors: overlapping and distinct functions.
[10769197] J Cell Sci 113 ( Pt 10)(-): 1661-70 (2000)
1994  
47
Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages.
[7919359] Blood 84(8): 2391-411 (1994)
2009  
48
Guarding the guardian: Mdmx plays important roles in setting p53 basal activity and determining biological responses in vivo.
[19838055] Cell Cycle 8(21): 3443-4 (2009)
2004  
49
p73 and p63: why do we still need them?
[15254416] Cell Cycle 3(7): 886-94 (2004)
2006  
50
The complexity of p53 stabilization and activation.
[16601750] Cell Death Differ 13(6): 941-50 (2006)
2006  
51
Transcriptional regulation by p53: one protein, many possibilities.
[16575405] Cell Death Differ 13(6): 951-61 (2006)
2006  
52
The P53 pathway: what questions remain to be explored?
[16557269] Cell Death Differ 13(6): 1027-36 (2006)
2006  
53
p53 and disease: when the guardian angel fails.
[16557268] Cell Death Differ 13(6): 1017-26 (2006)
2006  
54
Strategies for therapeutic targeting of the p53 pathway in cancer.
[16557267] Cell Death Differ 13(6): 921-6 (2006)
1996  
55
1998  
56
1992  
57
The p53 tumor suppressor protein, a modulator of cell proliferation.
[1639769] J Biol Chem 267(22): 15259-62 (1992)
1997  
58
p53-dependent signal transduction induced by stress.
[9415750] J Radiat Res (Tokyo) 38(3): 179-94 (1997)
2007  
59
p53 enters the microRNA world.
[17996645] Cancer Cell 12(5): 414-8 (2007)
2001  
60
1998  
61
Signaling to p53: breaking the MDM2-p53 circuit.
[9778240] Cell 95(1): 5-8 (1998)
2001  
62
Nuclear and mitochondrial apoptotic pathways of p53.
[11286997] FEBS Lett 493(2-3): 65-9 (2001)
2004  
63
The potential roles of p53 tumor suppressor in nucleotide excision repair (NER) and base excision repair (BER).
[15665582] Exp Mol Med 36(6): 505-9 (2004)
2002  
64
p53 Induction: phosphorylation sites cooperate in regulating.
[12432278] Cancer Biol Ther 1(3): 284-6 (2002)
2010  
65
Making sense of ubiquitin ligases that regulate p53.
[20930521] Cancer Biol Ther 10(7): 665-72 (2010)
2003  
66
The thousand doors that lead to death: p53-dependent repression and apoptosis.
[14508109] Cancer Biol Ther 2(4): 381-2 (2003)
2003  
67
Restoring p53-dependent tumor suppression.
[14508081] Cancer Biol Ther 2(4 Suppl 1): S55-63 (2003)
2009  
68
The isolation, total synthesis and structure elucidation of chlorofusin, a natural product inhibitor of the p53-mDM2 protein-protein interaction.
[19642417] Nat Prod Rep 26(4): 465-77 (2009)
2010  
69
SIRT1 and p53, effect on cancer, senescence and beyond.
[20471503] Biochim Biophys Acta 1804(8): 1684-9 (2010)
2009  
70
2006  
71
Modulating molecular functions of p53 with small molecules.
[17172837] Cell Cycle 5(22): 2575-8 (2006)
2010  
72
Shifting senescence into quiescence by turning up p53.
[20980826] Cell Cycle 9(21): 4256-7 (2010)
2010  
73
Removing all obstacles: a critical role for p53 in promoting tissue renewal.
[20234190] Cell Cycle 9(7): 1313-9 (2010)
2003  
74
p53 in a crosstalk between DNA repair and cell cycle checkpoints.
[12734432] Cell Cycle 2(3): 233-5 (2003)
2010  
75
Protecting the hedgerow: p53 and hedgehog pathway interactions.
[20081367] Cell Cycle 9(3): 506-11 (2010)
2007  
76
The role of ubiquitination in the direct mitochondrial death program of p53.
[17630506] Cell Cycle 6(14): 1718-23 (2007)
2007  
77
Targeting the p53 family for cancer therapy: 'big brother' joins the fight.
[17721076] Cell Cycle 6(16): 1995-2000 (2007)
2007  
78
Gain of function of p53 cancer mutants in disrupting critical DNA damage response pathways.
[17598983] Cell Cycle 6(13): 1570-3 (2007)
2007  
79
p53 reactivation kills KSHV lymphomas efficiently in vitro and in vivo: new hope for treating aggressive viral lymphomas.
[17890905] Cell Cycle 6(18): 2205-9 (2007)
2007  
80
Tiny actors, great roles: microRNAs in p53's service.
[17957137] Cell Cycle 6(21): 2656-61 (2007)
2007  
81
S6-haploinsufficiency activates the p53 tumor suppressor.
[17245121] Cell Cycle 6(1): 20-4 (2007)
2007  
82
p53 induced growth arrest versus apoptosis and its modulation by survival cytokines.
[17264673] Cell Cycle 6(2): 166-70 (2007)
2007  
83
Distinct roles of MDMX in the regulation of p53 response to ribosomal stress.
[17327702] Cell Cycle 6(2): 151-5 (2007)
2009  
84
Cell cycle arrest or apoptosis by p53: are microRNAs-192/215 and -34 making the decision?
[19223766] Cell Cycle 8(5): 680-1 (2009)
2011  
85
Recent advances in p53 research and cancer treatment.
[21765642] J Biomed Biotechnol 2011(-): 978312 (2011)
2011  
86
One function--multiple mechanisms: the manifold activities of p53 as a transcriptional repressor.
[21436991] J Biomed Biotechnol 2011(-): 464916 (2011)
2011  
87
Immunological and clinical effects of vaccines targeting p53-overexpressing malignancies.
[21541192] J Biomed Biotechnol 2011(-): 702146 (2011)
2011  
88
Functions of MDMX in the modulation of the p53-response.
[21541195] J Biomed Biotechnol 2011(-): 876173 (2011)
2011  
89
p53: the attractive tumor suppressor in the cancer research field.
[21188172] J Biomed Biotechnol 2011(-): 603925 (2011)
2010  
90
p53-family proteins and their regulators: hubs and spokes in tumor suppression.
[20379196] Cell Death Differ 17(6): 901-11 (2010)
2003  
91
Regulation of p53 responses by post-translational modifications.
[12719715] Cell Death Differ 10(4): 400-3 (2003)
2003  
92
Transcriptional repression mediated by the p53 tumour suppressor.
[12719716] Cell Death Differ 10(4): 404-8 (2003)
2003  
93
Renewing the debate over the p53 apoptotic response.
[12719717] Cell Death Differ 10(4): 409-12 (2003)
2003  
94
Decision making by p53: life, death and cancer.
[12719720] Cell Death Differ 10(4): 431-42 (2003)
2010  
95
p53 stabilization: the importance of nuclear import.
[20062067] Cell Death Differ 17(2): 191-2 (2010)
2010  
96
Mdm2-mediated ubiquitylation: p53 and beyond.
[19498444] Cell Death Differ 17(1): 93-102 (2010)
2010  
97
The multiple levels of regulation by p53 ubiquitination.
[19543236] Cell Death Differ 17(1): 86-92 (2010)
2010  
98
Ubiquitin-independent p53 proteasomal degradation.
[19557012] Cell Death Differ 17(1): 103-8 (2010)
2010  
99
The miR-34 family in cancer and apoptosis.
[19461653] Cell Death Differ 17(2): 193-9 (2010)
2007  
100
How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?
[17627286] Cell Death Differ 14(9): 1561-75 (2007)
2008  
101
The dark side of a tumor suppressor: anti-apoptotic p53.
[18356920] Cell Death Differ 15(6): 959-76 (2008)
2009  
102
Escape from p53-mediated tumor surveillance in neuroblastoma: switching off the p14(ARF)-MDM2-p53 axis.
[19779493] Cell Death Differ 16(12): 1563-72 (2009)
2006  
103
p53: more research and more questions.
[16708075] Cell Death Differ 13(6): 877-80 (2006)
2006  
104
p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
[16601753] Cell Death Differ 13(6): 962-72 (2006)
2006  
105
Mouse bites dogma: how mouse models are changing our views of how P53 is regulated in vivo.
[16575406] Cell Death Differ 13(6): 973-83 (2006)
2006  
106
Some p53-binding proteins that can function as arbiters of life and death.
[16575404] Cell Death Differ 13(6): 984-93 (2006)
2006  
107
Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice.
[16557272] Cell Death Differ 13(6): 902-8 (2006)
2006  
108
Sliding into home: facilitated p53 search for targets by the basic DNA binding domain.
[16557271] Cell Death Differ 13(6): 881-4 (2006)
2006  
109
Polymorphic variants in the p53 pathway.
[16557270] Cell Death Differ 13(6): 916-20 (2006)
2006  
110
Lessons from p53 in non-mammalian models.
[16557266] Cell Death Differ 13(6): 909-12 (2006)
2006  
111
Translational research? Ribosome integrity and a new p53 tumor suppressor checkpoint.
[16557265] Cell Death Differ 13(6): 898-901 (2006)
2006  
112
2006  
113
The functional domains in p53 family proteins exhibit both common and distinct properties.
[16543939] Cell Death Differ 13(6): 890-7 (2006)
2006  
114
Dissecting p53-dependent apoptosis.
[16543937] Cell Death Differ 13(6): 994-1002 (2006)
2006  
115
The versatile interactions of p53 with DNA: when flexibility serves specificity.
[16543936] Cell Death Differ 13(6): 885-9 (2006)
2006  
116
Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4.
[16543935] Cell Death Differ 13(6): 927-34 (2006)
2010  
117
2006  
118
AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer.
[16613876] J Physiol 574(Pt 1): 63-71 (2006)
2010  
119
Potentiating the p53 network.
[20670604] Discov Med 10(50): 94-100 (2010)
2010  
120
The origins and evolution of the p53 family of genes.
[20516129] Cold Spring Harb Perspect Biol 2(6): a001198 (2010)
2010  
121
The tumor suppressor p53: from structures to drug discovery.
[20516128] Cold Spring Harb Perspect Biol 2(6): a000919 (2010)
2010  
122
Single-nucleotide polymorphisms in the p53 signaling pathway.
[20452958] Cold Spring Harb Perspect Biol 2(5): a001032 (2010)
2010  
123
2010  
124
Clinical outcomes and correlates of TP53 mutations and cancer.
[20300207] Cold Spring Harb Perspect Biol 2(3): a001016 (2010)
2010  
125
Tied up in loops: positive and negative autoregulation of p53.
[20452957] Cold Spring Harb Perspect Biol 2(5): a000984 (2010)
2010  
126
The regulation of the p53-mediated stress response by MDM2 and MDM4.
[20182601] Cold Spring Harb Perspect Biol 2(1): a000968 (2010)
2010  
127
TP53 mutations in human cancers: origins, consequences, and clinical use.
[20182602] Cold Spring Harb Perspect Biol 2(1): a001008 (2010)
2010  
128
p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment.
[20182617] Cold Spring Harb Perspect Biol 2(2): a001057 (2010)
2010  
129
2008  
130
A role for Numb in p53 stabilization.
[18492217] Genome Biol 9(5): 221 (2008)
2011  
131
p53 and its mutants in tumor cell migration and invasion.
[21263025] J Cell Biol 192(2): 209-18 (2011)
2010  
132
The history of p53. A perfect example of the drawbacks of scientific paradigms.
[20930848] EMBO Rep 11(11): 822-6 (2010)
2010  
133
Applications of the human p53 knock-in (Hupki) mouse model for human carcinogen testing.
[20371617] FASEB J 24(8): 2612-9 (2010)
2007  
134
Versatile functions of p53 protein in multicellular organisms.
[18282133] Biochemistry (Mosc) 72(13): 1399-421 (2007)
2007  
135
MDM2 and MDM4: p53 regulators as targets in anticancer therapy.
[17499002] Int J Biochem Cell Biol 39(7-8): 1476-82 (2007)
2007  
136
DRAM links autophagy to p53 and programmed cell death.
[17102582] Autophagy 3(1): 72-4 (2007)
2011  
137
p53 regulation of podosome formation and cellular invasion in vascular smooth muscle cells.
[21164280] Cell Adh Migr 5(2): 144-9 (2011)
2007  
138
ASPP: a new family of oncogenes and tumour suppressor genes.
[17211478] Br J Cancer 96(2): 196-200 (2007)
2008  
139
Updates on p53: modulation of p53 degradation as a therapeutic approach.
[18182973] Br J Cancer 98(1): 4-8 (2008)
2006  
140
Jab1 as a mediator of nuclear export and cytoplasmic degradation of p53.
[17085963] Mol Cells 22(2): 133-40 (2006)
2009  
141
Watching the watcher: regulation of p53 by mitochondria.
[19243304] Future Oncol 5(1): 117-30 (2009)
2007  
142
Dangerous habits of a security guard: the two faces of p53 as a drug target.
[17613549] Hum Mol Genet 16 Spec No 1(-): R67-72 (2007)
2010  
143
The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor.
[20679392] Genes Dev 24(15): 1580-9 (2010)
2005  
144
p53: link to the past, bridge to the future.
[16166374] Genes Dev 19(18): 2091-9 (2005)
2002  
145
Having it both ways: transcription factors that bind DNA and RNA.
[12364590] Nucleic Acids Res 30(19): 4118-26 (2002)
2007  
146
Two faces of p53: aging and tumor suppression.
[17942417] Nucleic Acids Res 35(22): 7475-84 (2007)
2011  
147
The RP-Mdm2-p53 pathway and tumorigenesis.
[21406728] Oncotarget 2(3): 234-8 (2011)
2010  
148
The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein.
[20399660] Trends Cell Biol 20(7): 427-34 (2010)
2010  
149
p53 and ARF: unexpected players in autophagy.
[20303758] Trends Cell Biol 20(6): 363-9 (2010)
2010  
150
The p53 orchestra: Mdm2 and Mdmx set the tone.
[20172729] Trends Cell Biol 20(5): 299-309 (2010)
2009  
151
Homeostatic functions of the p53 tumor suppressor: regulation of energy metabolism and antioxidant defense.
[19101635] Semin Cancer Biol 19(1): 32-41 (2009)
2011  
152
Skp2 and Skp2B team up against Rb and p53.
[21255415] Cell Div 6(1): 1 (2011)
2007  
153
The anti-apoptotic factor Che-1/AATF links transcriptional regulation, cell cycle control, and DNA damage response.
[17634135] Cell Div 2(-): 21 (2007)
2010  
154
In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models.
[20097732] Carcinogenesis 31(8): 1311-8 (2010)
2010  
155
p53 is balancing development, differentiation and de-differentiation to assure cancer prevention.
[20504879] Carcinogenesis 31(9): 1501-8 (2010)
2005  
156
Complicating the complexity of p53.
[15888490] Carcinogenesis 26(8): 1317-22 (2005)
2008  
157
IL-24 induces apoptosis of chronic lymphocytic leukemia B cells engaged into the cell cycle through dephosphorylation of STAT3 and stabilization of p53 expression.
[18941194] J Immunol 181(9): 6051-60 (2008)
2007  
158
The roles of synoviolin in crosstalk between endoplasmic reticulum stress-induced apoptosis and p53 pathway.
[17582219] Cell Cycle 6(11): 1319-23 (2007)
2004  
159
Control of tumor suppressor p53 function by endoplasmic reticulum stress.
[15107622] Cell Cycle 3(5): 567-70 (2004)
2007  
160
Therapeutic targets in the ARF tumor suppressor pathway.
[17627519] Curr Med Chem 14(17): 1815-27 (2007)
2010  
161
Tumor suppression by p53: making cells senescent.
[20183804] Histol Histopathol 25(4): 515-26 (2010)
2008  
162
Protein methylation: a new mechanism of p53 tumor suppressor regulation.
[18581285] Histol Histopathol 23(9): 1143-9 (2008)
2006  
163
Ubiquitin and ubiquitin-like modifications of the p53 family.
[16925948] Neoplasia 8(8): 655-66 (2006)
2006  
164
Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc.
[16925946] Neoplasia 8(8): 630-44 (2006)
2009  
165
Running on empty: how p53 controls INS/IGF signaling and affects life span.
[18598747] Exp Gerontol 44(1-2): 93-100 (2009)
2009  
166
Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy.
[18834305] Annu Rev Pharmacol Toxicol 49(-): 223-41 (2009)
2011  
167
Pathology of hereditary breast cancer.
[21336636] Cell Oncol (Dordr) 34(2): 71-88 (2011)
2010  
168
p53 connects tumorigenesis and reprogramming to pluripotency.
[20876313] J Exp Med 207(10): 2045-8 (2010)
2011  
169
The Role of p53 in Metabolic Regulation.
[21779507] Genes Cancer 2(4): 385-91 (2011)
2011  
170
The Regulation of Aging and Longevity: A New and Complex Role of p53.
[21779512] Genes Cancer 2(4): 443-52 (2011)
2011  
171
p53 Isoforms: An Intracellular Microprocessor?
[21779513] Genes Cancer 2(4): 453-65 (2011)
2011  
172
Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis.
[21779514] Genes Cancer 2(4): 466-74 (2011)
2009  
173
Cytoplasmic functions of the tumour suppressor p53.
[19407794] Nature 458(7242): 1127-30 (2009)
2011  
174
Tumor suppressor p53 meets microRNAs.
[21278451] J Mol Cell Biol 3(1): 44-50 (2011)
2007  
175
p53 RNA interactions: new clues in an old mystery.
[17804642] RNA 13(11): 1825-33 (2007)
2009  
176
Transcriptional targets for pituitary tumor-transforming gene-1.
[19433493] J Mol Endocrinol 43(5): 179-85 (2009)
2010  
177
p53 post-translational modification: deregulated in tumorigenesis.
[20932800] Trends Mol Med 16(11): 528-36 (2010)
2011  
178
AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan.
[21431325] J Mol Med (Berl) 89(7): 667-76 (2011)
2011  
179
2011  
180
2008  
181
Posttranscriptional regulation of p53 and its targets by RNA-binding proteins.
[19075680] Curr Mol Med 8(8): 845-9 (2008)
2010  
182
New insights into p53 activation.
[20404858] Cell Res 20(6): 614-21 (2010)
2007  
183
p53 and Bad: remote strangers become close friends.
[17404594] Cell Res 17(4): 283-5 (2007)
2007  
184
2011  
185
Reciprocal influence of the p53 and the hypoxic pathways.
[21614094] Cell Death Dis 2(-): e164 (2011)
2007  
186
p53 and the pathogenesis of skin cancer.
[17270229] Toxicol Appl Pharmacol 224(3): 241-8 (2007)
2010  
187
Constitutive and induced functions of the p53 gene.
[21418001] Biochemistry (Mosc) 75(13): 1692-721 (2010)
2010  
188
The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
[20922462] Cancer Metastasis Rev 29(4): 613-39 (2010)
2010  
189
p53 Research: the past thirty years and the next thirty years.
[20463001] Cold Spring Harb Perspect Biol 2(12): a000893 (2010)
2010  
190
Restoring p53 tumor suppressor activity as an anticancer therapeutic strategy.
[21142860] Future Oncol 6(12): 1857-62 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.



  • P53

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia